How to Build Your Online Media Presence
“I read great things about you on Yelp” is something that a chef at a restaurant would normally hear. Unfortunately, this phrase is becoming more and more common in the medical setting. And although most physicians would cringe when hearing that phrase, a recent survey of 1700 adults showed that 63% of respondents would choose to see a physician with a stronger online presence. This trend will …
“I read great things about you on Yelp” is something that a chef at a restaurant would normally hear. Unfortunately, this phrase is becoming more and more common in the medical setting. And although most physicians would cringe when hearing that phrase, a recent survey of 1700 adults showed that 63% of respondents would choose to see a physician with a stronger online presence. This trend will …
Acne is a common skin condition that can be an important clue to an underlying endocrine disorder, such as polycystic ovarian syndrome (PCOS, Fig. 1). The first part of this 2-part series focused on the diagnosis and pathophysiology of PCOS-related acne. This article will focus on the diagnostic workup, including laboratory studies and imaging, and treatment options for patients with hormonal acne …
During the month of September, Next Steps in Derm Ask the Expert segment gives you access to Dr. Joshua Zeichner, Director of Cosmetic and Clinical Research in Dermatology at Mount Sinai Hospital in New York City. Dr. Zeichner is one of the country's key opinion leaders in treating acne and is an expert in cosmeceuticals and skin care.
If you have questions for Dr. Zeichner on any of his area …
This month’s Patient Buzz includes warnings for consumers: Fake facial fillers for sale online. A recall of a popular at-home light therapy mask. An acne treatment promoted by a celebrity that may irritate the skin.
Be prepared for the questions your patients may ask by perusing this list of dermatology news from the consumer press:
Allure: Fake facial fillers
Allure: Scalp acne
Bu …
Abstract
Botulinum toxin type A (BTA) is a neurotoxic protein that prevents the release of neurotransmitters from presynaptic nerves and has shown promise in treating neuropathic pain. Recently, BTA has been used to treat painful keloids and scars. We present a patient with refractory neuropathic pain in a normotrophic spread-scar treated with the injection of BTA.
A 47-year-old Caucasian female …